Based in in Cambridge, Massachusetts, Sproxil provides a consumer SMS verification service through its Mobile Product Authentication (MPA) solution.

The technology empowers consumers in the war against product counterfeiting by using a cell phone to verify that they purchased a genuine product. Sproxil’s service is currently being used by several pharmaceutical companies in the fight against counterfeit drugs.

According to the World Customs Organization, the fake drug market is estimated to be a $200 Billion a year industry. The problem of counterfeit drugs is particularly acute in emerging markets, where an estimated 30% of drugs are fake and may be harmful or lethal to consumers.

Sproxil’s service places a scratch-off label on products. After purchasing a product, consumers scratch off the label to reveal a unique, random code. The code is sent via SMS to a country-specific short code, and the consumer receives a reply almost instantly indicating whether the product is genuine or not.

Check out a brief interview with Sproxil CEO Ashifi Gogo below.

Interested in other Fast Company Top 10 Most Innovative Companies in Healthcare 2013? Check them all out with the tag Fast Company 2013 Most Innovative Healthcare.

References

1. The World’s Top 10 Most Innovative Companies in Health Care. Fast Company. 2013 Feb 11.

The collaboration between the two companies aims to expand iRx Reminder’s bidirectional smartphone-based solutions focused on improving real-time data collection and lowering costs of clinical trials.

iRx Reminder is an Akron, Ohio-based mobile health application service provider focused on medicine, device, and behavior research. The iRx Reminder smartphone app provides for the direct capture of in-the-moment, electronic data from patients and clinical study participants. Digital data is sent from the patient’s smartphone to a web accessible control center in real time.

Based in New York, New Directions Technology Consulting is a healthcare consultancy that develops commercial opportunities for its corporate, trade and professional associations. New Directions Technology Consulting is the exclusive market developer of the mMed mobile medication management patent portfolio, which goes beyond “take your medicine” reminders, “refill your prescription” alerts, and self-tracking solutions. The mMed mobile medication management patent portfolio could provide the foundation for tools to help patients outside the doctor’s office or hospital to take actions required to make and keep themselves well.

mMed’s patents apply to securing usage information for medication and other healthcare products in the hands of patients, away from physical locations of medical professionals, and cover the possible development of an auto-injector with embedded sensors, enabling a medication carrying case with reporting ability and incorporating a central monitoring facility with medical professionals to intervene and enable medical management.

Couple mMed technology with iRx Reminder’s bidirectional smartphone communications, which enables tracking, reporting, feedback and interactions for data gathering or education, and you have the key to clinical protocol compliance and clinical trial success. In a press release [1], iRx Reminder founder and CEO Anthony Sterns, Ph.D., said:

Combining our patented technologies with the mMed portfolio will let us enhance our SaaS mobile health offering, which already has been shown to reduce dropout rates, improve data accuracy and speed up completion times of clinical trials. As a licensee of the mMed patents, iRx Reminder can expand its options for monitoring protocol compliance and improving medication adherence with a variety of drug-delivery systems, including tablets, capsules, injectables and inhalers.

Mobile application developers are starting to enable the mHealth industry to successfully monetize their services. The market for mHealth services has now entered the commercialization phase and is expected to reach $26 billion globally by 2017 [2].

References

1. New Directions Technology Consulting Inks Deal with iRx Reminder to Co-develop Bidirectional, mHealth, Smartphone Solutions for Clinical Trials. New Directions Technology Consulting. 2013 Apr 23.
2. Global Mobile Health Market Report 2013-2017. research2guidance. 2013 March.

The GlucoDock is just one of the devices that can be connected to an iPhone or iPad to measure and record health information through the VitaDock software. Other devices include the ThermoDock, which measures body (or room) temperature via infrared, the CardioDock, which uses a cuff to measure and track blood pressure, and the TargetScale, which calculates a variety of body composition metrics, including body mass index (a ratio of weight to height) and body fat percentage.

Source: VitaDock

The mobile diagnostic device measures key vital signs — blood pressure, pulmonary function, temperature — and may even be able to read simple samples, sending all information directly to your smartphone. The Medical Tricorder additionally asks screening questions to provide recommendations.

According to the video below, the device can alert you about flu or disease outbreaks tailored to your family’s needs and offers advice on what to do next.

Source: Scanadu

From the iglucose website:

iglucose is a diabetes management solution that provides a convenient way to collect, store and automatically transmit blood glucose readings from compatible glucometers in real time. iglucose easily connects to industry leading, data-capable glucometers. Once glucometer data is transmitted to a secure central database, logbooks and trend reports are automatically created and can be communicated to individuals, family members, caregivers and health care professionals in order to collaborate for better outcomes. iglucose is mobile: it can be used anytime, anywhere.

The iglucose is the first core product in a suite of diabetes management technologies from PositiveID Corporation.

Source: PRWeb